Taipei, Taiwan

Chan-Hsien Yeh

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chan-Hsien Yeh. Retrieved from https://idiyas.com/inventor/chan-hsien-yeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chan-Hsien Yeh in Neural Progenitor Cell Research

Introduction

Chan-Hsien Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of neuroscience through his innovative research and patents. His work focuses on the development of methods and kits for producing induced embryonic neural progenitor cells, which have important implications for treating neurological diseases.

Latest Patents

One of Chan-Hsien Yeh's notable patents is titled "Kit and method for producing induced embryonic neural progenitors." This patent discloses kits that comprise transcription factors for inducing fibroblast cells into induced embryonic neural progenitor cells. These induced cells are capable of differentiating into various types of neural cells, including astrocytes, oligodendrocytes, and neurons. The patent also highlights the uses of the kit as a platform for selecting drug candidates to treat neurological diseases. Chan-Hsien Yeh holds 1 patent in this area.

Career Highlights

Chan-Hsien Yeh is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with other leading researchers in the field, further advancing the understanding of neural progenitor cells and their potential applications in medicine.

Collaborations

Some of Chan-Hsien Yeh's notable coworkers include Hung-Chih Kuo and Ching-Yu Chuang. Their collaborative efforts contribute to the innovative research being conducted at Academia Sinica.

Conclusion

Chan-Hsien Yeh's contributions to the field of neuroscience through his patent on induced embryonic neural progenitor cells demonstrate his commitment to advancing medical science. His work has the potential to pave the way for new treatments for neurological diseases, showcasing the importance of innovation in research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…